Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Nurix Therapeutics
NRIX
$2.41B
| $641K | ﹤0.01% |
72,147
-27,510
| -28% | -$287K |
|
3002
Sony
SONY
$133B
| $640K | ﹤0.01% |
35,325
-435
| -1% | -$7.54K |
|
3003
Ichor Holdings
ICHR
$2.8B
| $640K | ﹤0.01% |
19,556
-708
| -3% | -$22.7K |
|
3004
The Greenbrier Companies
GBX
$1.54B
| $640K | ﹤0.01% |
19,885
+4,181
| +27% | +$126K |
|
3005
Accel Entertainment
ACEL
$979M
| $639K | ﹤0.01% |
70,166
+13,309
| +23% | +$120K |
|
3006
Cerence
CRNC
$403M
| $639K | ﹤0.01% |
22,751
+1,926
| +9% | +$49.4K |
|
3007
ENI
E
$79B
| $639K | ﹤0.01% |
22,808
-304
| -1% | -$8.9K |
|
3008
US Physical Therapy
USPH
$1.18B
| $638K | ﹤0.01% |
6,521
+273
| +4% | +$26K |
|
3009
F&G Annuities & Life
FG
$3.85B
| $638K | ﹤0.01% |
35,195
+31,154
| +771% | +$624K |
|
|
CSII
3010
DELISTED
Cardiovascular Systems, Inc.
CSII
| $636K | ﹤0.01% |
32,041
-13,781
| -30% | -$238K |
|
|
AVTA
3011
DELISTED
Avantax, Inc. Common Stock
AVTA
| $636K | ﹤0.01% |
24,152
+1,065
| +5% | +$28.9K |
|
3012
Zegna
ZGN
$4.09B
| $635K | ﹤0.01% |
46,569
+23,287
| +100% | +$288K |
|
3013
Spok Holdings
SPOK
$232M
| $635K | ﹤0.01% |
62,647
+24,894
| +66% | +$227K |
|
3014
LSI Industries
LYTS
$886M
| $634K | ﹤0.01% |
45,546
+13,967
| +44% | +$193K |
|
3015
Vitesse Energy
VTS
$647M
| $634K | ﹤0.01% |
+33,338
| New | +$575K |
|
3016
RadNet
RDNT
$5.25B
| $634K | ﹤0.01% |
25,327
+1,435
| +6% | +$31.2K |
|
3017
indie Semiconductor
INDI
$716M
| $634K | ﹤0.01% |
60,080
+32,668
| +119% | +$292K |
|
3018
QCR Holdings
QCRH
$1.71B
| $633K | ﹤0.01% |
14,423
+7,394
| +105% | +$369K |
|
3019
ProShares UltraPro Short Dow 30
SDOW
$144M
| $632K | ﹤0.01% |
6,000
| – | – |
|
3020
National Beverage
FIZZ
$2.95B
| $632K | ﹤0.01% |
11,979
+618
| +5% | +$28.8K |
|
|
LICY
3021
DELISTED
Li-Cycle Holdings Corp.
LICY
| $631K | ﹤0.01% |
14,009
+8,662
| +162% | +$382K |
|
|
BRY
3022
DELISTED
Berry Corp
BRY
| $631K | ﹤0.01% |
80,338
+27,823
| +53% | +$241K |
|
3023
Myers Industries
MYE
$1.38B
| $630K | ﹤0.01% |
29,419
+11,824
| +67% | +$269K |
|
3024
Napco Security Technologies
NSSC
$1.36B
| $629K | ﹤0.01% |
16,734
+8,455
| +102% | +$269K |
|
3025
Standard Motor Products
SMP
$863M
| $629K | ﹤0.01% |
17,036
+4,283
| +34% | +$163K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.